针对肌肉蛋白受体治疗精神分裂症
Steven M Paul1, Samantha E Yohn2
1Departments of Psychiatry and Neurology, Washington University of St. Louis School of Medicine, USA.
概括
向肌酸乙胆受体 (mAChRs) 为精神分裂症提供了一个新的治疗途径,超出了多巴胺D2抗剂. 临床试验证实mAChR激动剂有效地减少精神病症状,改善耐受性.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 精神分裂症呈现复杂的正面,负面和认知症状.
- 目前的多巴胺D2受体对手具有有限的疗效和显著的副作用.
- 肌肉酸乙胆受体 (mAChRs) 是神经传递的关键调节者,与精神分裂症有关.
研究的目的:
- 探索针对精神分裂症的M1和M4肌肉酸乙胆受体的治疗潜力.
- 评估mAChR激动剂在治疗精神分裂症症状中的有效性和耐受性.
主要方法:
- 临床研究涉及xanomeline,一个M1 / M4偏好的正性激动剂.
- 用克萨诺梅林与化进行重新配方,以提高耐受性.
- 第二期和第三期临床试验,以确认疗效和安全性.
主要成果:
- 赞诺梅林在减少精神病症状方面表现出有效性.
- 与化托联合使用改善了耐受性,使得大规模试验得到证实.
- mAChR激动剂代表了一种经过临床验证的战略,超越了多巴胺对抗作用.
结论:
- 肌肉酸乙胆受体药理学是一种有希望的,临床验证的精神分裂症治疗策略.
- 针对M1和M4受体提供了一种新的方法来解决精神分裂症症状的全谱.
- 目前正在进行的研究重点是开发有选择性的mAChR激动剂,以改善治疗结果.
相关概念视频
Cholinergic Receptors: Muscarinic
5.1K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
5.1K
Antiasthma Drugs: Muscarinic Receptor Antagonists
1.8K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.8K
Schizophrenia
974
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
974
Biological Causes of Schizophrenia
626
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
626
Psychological and Sociocultural Causes of Schizophrenia
619
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
619
Negative and Cognitive Symptoms of Schizophrenia
580
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
580


